The sharp edge of immunosuppressive treatments: infections
Turkish Journal of Medical Sciences · 23.08.2024 · 54 (4) · 752-760
DOI: 10.55730/1300-0144.5845 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 23.08.2024. Verfasst von Aybegüm Özşahin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Recep Tayyip Erdoğan University Training and Research Hospital, Rize, Turkiye. Hauptthemen laut MEDLINE: Interleukin 1 Receptor Antagonist Protein, Antibodies, Monoclonal, Humanized, Immunosuppressive Agents, COVID-19. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and aim: Different side effects, including infections, are encountered in patients receiving anticytokines used for the treatment of severe coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate the infections and the effects of these infections that develop in this patient group. Materials and Methods: This study included 208 patients who were followed-up with the diagnosis of severe COVID-19 in two different hospitals. Patient data were obtained retrospectively from the hospital information system.
Results
Of the 208 patients included, 54 were in the anakinra group, and 154 were in the tocilizumab group. Of these patients, 73 (35.1%) developed infection, 160 (76.9%) were admitted to the intensive care unit (ICU), and the 30-day mortality rate was 46.6%. The ICU admission, 30-day mortality, and infection rates were higher in the anakinra group, but it was not statistically significant (p = 0.137, p = 0.127, and p = 0.132, respectively), while pneumonia and bloodstream infection (BSI) rates were higher (p = 0.043 and p = 0.010 respectively). The 30-day mortality rate was significantly higher in patients who developed infection, especially in the tocilizumab group (p < 0.001 and p = 0.001). The independent risk factors affecting the development of infection were evaluated via regression analysis, in which it was found that age, sex, and the type of immunosuppressive treatment had no significant effect, while ICU admission increased the risk of infection by 32.8 times (95% CI: 4.4–245.8) and each day of hospitalization slightly increased the risk of infection by 1.06 times (95% CI: 1.03–1.09).
Conclusion
Infection rates were higher in the anakinra group, especially the pneumonia and BSI rates were higher than in the tocilizumab group. The 30-day mortality rates were higher in patients who had an infection, especially in the tocilizumab group. This is one of the rare studies that evaluated infections developing in patients treated with anakinra and tocilizumab together.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Recep Tayyip Erdoğan University Training and Research Hospital, Rize, Turkiye.
- Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Recep Tayyip Erdoğan University, Rize, Turkiye.
- Department of Pulmonary Diseases, Üsküdar State Hospital, İstanbul, Turkiye.
- Department of Public Health, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkiye.
ORCID-Profile: Aybegüm Özşahin, Tuba Ilgar, Sudem Mahmutoğlu Çolak, Kübra Akyüz, Melih Gaffar Gözükara, Uğur Kostakoğlu, İlknur Esen Yildiz, Ayşe Ertürk
Zitieren
APA
Özşahin, A., Ilgar, T., Mahmutoğlu Çolak, S., Akyüz, K., Gözükara, M. G., Kostakoğlu, U., Yildiz, İ. E., & Ertürk, A. (2024). The sharp edge of immunosuppressive treatments: infections. Turkish Journal of Medical Sciences, 54(4), 752-760. https://doi.org/10.55730/1300-0144.5845
Vancouver
Özşahin A, Ilgar T, Mahmutoğlu Çolak S, Akyüz K, Gözükara MG, Kostakoğlu U, et al. The sharp edge of immunosuppressive treatments: infections. Turkish Journal of Medical Sciences. 2024;54(4):752-760. doi:10.55730/1300-0144.5845
BibTeX
@article{zahin2024,
author = {Özşahin, Aybegüm and Ilgar, Tuba and Mahmutoğlu Çolak, Sudem and Akyüz, Kübra and Gözükara, Melih Gaffar and Kostakoğlu, Uğur and Yildiz, İlknur Esen and Ertürk, Ayşe},
title = {The sharp edge of immunosuppressive treatments: infections},
journal = {Turkish Journal of Medical Sciences},
year = {2024},
volume = {54},
number = {4},
pages = {752--760},
doi = {10.55730/1300-0144.5845}
}
EUVIMED